Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification.
Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, Jung N, Chimal EC, Jung A, Kumbrink J, Harter P, Prenißl N, Elezkurtaj S, Brcic L, Deigendesch N, Frank S, Hench J, Försch S, Breimer G, van Engen van Grunsven I, Lassche G, van Herpen C, Zhou F, Snuderl M, Agaimy A, Müller KR, von Deimling A, Capper D, Klauschen F, Ihrler S. Jurmeister P, et al. Among authors: lassche g. Mod Pathol. 2024 Dec;37(12):100625. doi: 10.1016/j.modpat.2024.100625. Epub 2024 Sep 25. Mod Pathol. 2024. PMID: 39332710 Free article.
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
Weijers JAM, Verhaegh GW, Lassche G, van Engen-van Grunsven ACH, Driessen CML, van Erp NP, Jonker MA, Schalken JA, van Herpen CML. Weijers JAM, et al. Among authors: lassche g. BMC Cancer. 2024 Sep 20;24(1):1174. doi: 10.1186/s12885-024-12889-0. BMC Cancer. 2024. PMID: 39304797 Free PMC article.
Cutaneous lymphangitis carcinomatosa in salivary duct carcinoma.
Uijen MJ, Weijers JA, Lassche G, van Ravensteijn SG, van Rijk MC, Lubeek SF, van Engen-van Grunsven AC, Amir A, Driessen CM, van Herpen CM. Uijen MJ, et al. Among authors: lassche g. J Clin Pathol. 2023 Mar;76(3):211-213. doi: 10.1136/jcp-2022-208564. Epub 2022 Nov 8. J Clin Pathol. 2023. PMID: 36347591 No abstract available.
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma.
Uijen MJM, Lassche G, van Engen-van Grunsven ACH, Driessen CML, van Herpen CML. Uijen MJM, et al. Among authors: lassche g. Oral Oncol. 2022 Feb;125:105703. doi: 10.1016/j.oraloncology.2021.105703. Epub 2022 Jan 4. Oral Oncol. 2022. PMID: 34995931 Free article.
Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade.
Lassche G, Tada Y, van Herpen CML, Jonker MA, Nagao T, Saotome T, Hirai H, Saigusa N, Takahashi H, Ojiri H, van Engen-Van Grunsven ACH, Schalken JA, Fushimi C, Verhaegh GW. Lassche G, et al. Cancers (Basel). 2021 Jul 14;13(14):3527. doi: 10.3390/cancers13143527. Cancers (Basel). 2021. PMID: 34298742 Free PMC article.
[Salivary gland carcinoma].
Lassche G, van Engen-van Grunsven ACH, Honings J, Dijkema T, Weijs WLJ, van Herpen CML. Lassche G, et al. Ned Tijdschr Geneeskd. 2020 Jul 16;164:D4760. Ned Tijdschr Geneeskd. 2020. PMID: 32779918 Dutch.
15 results